Free online education for Tennessee-specific prescribing guidelines
Resources in Section 2:
Treating SUD as a Disease
These tools are listed for reference as widely used clinical resources. Inclusion does not constitute endorsement by the Tennessee Foundation for Quality Patient Healthcare or the Tennessee Medical Association. Clinicians should apply professional judgment and current clinical guidelines when using any decision-support tool.
Screening, Brief Intervention, and Referral to Treatment (SBIRT):
https://www.samhsa.gov/substance-use/treatment/sbirt
DSM-5 Criteria for Diagnosing Opioid Use Disorder:
https://www.appi.org/Products/dsm
Guide to Substance Abuse Services for Primary Care Clinicians:
https://library.samhsa.gov/product/guide-substance-abuse-services-primary-care-clinicians/sma12-3581
Handout for Signs of Substance Use Disorder:
https://www.recoveryanswers.org/assets/SUD-DIAGNOSIS.png
Tennessee Nonresidential Buprenorphine Treatment Guidelines:
https://www.tn.gov/content/dam/tn/health/documents/Buprenorphine-Treatment-Guidelines.pdf
Clinical Opioid Withdrawal Scale:
https://nida.nih.gov/sites/default/files/ClinicalOpiateWithdrawalScale.pdf
Medication Interactions Guide:
-
https://www.merative.com/clinical-decision-support/micromedex
-
https://www.elsevier.com/products/clinicalkey/clinical-pharmacology
Restrictions for PAs and APRNs to Prescribe Buprenorphine:
https://www.tn.gov/content/dam/tn/health/documents/Buprenorphine-Treatment-Guidelines.pdf
SAMHSA Treatment Improvement Protocol 63:
https://library.samhsa.gov/product/tip-63-medications-opioid-use-disorder/pep21-02-01-002